CLINICAL_TRIALS
trial_result
· 2020-01-31
Clinical Trial Update: Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 [Phase 2]
Summary
Phase 2 clinical trial update on rasburicase for patients at high risk of tumor lysis syndrome during cycle 2; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-01-31